Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
暂无分享,去创建一个
J. Shuster | B. Camitta | D. Mahoney | R. Nitschke | S. Lauer | J. Shuster | C. Steuber | B. Camitta | Donald H. Mahoney | C. Steuber